Morning Market Losers

shares tumbled 66.40 percent to $15.74.

declined 25.50 percent to $8.59. 8:00 am Xenon Pharmaceuticals and Teva Pharmaceutical Industries Ltd (ADR)

issued an update on TV-45070 Phase 2b study in osteoarthritis pain.

shares dropped 18.66 percent to $1.70 after the company priced 8.125 million shares at $1.60 per share. Ballard expected Q2 sales of $10.6 million to $11.5 million.

shares declined 15.53 percent to $1.85. Peabody Energy expected adjusted EPS to be below the original targeted range.

shares fell 3.34 percent to $78.25. McCormick reported stronger-than-expected earnings for its fiscal second quarter, but the company's revenue missed analysts' expectations.

dropped 2.37 percent to $54.40. General Mills reported better-than-expected earnings for its fiscal fourth quarter, but the company's revenue missed analysts' estimates.

shares slipped 2.86 percent to $45.51 after the company reported downbeat Q3 results.